ReachMD

Episodes 1-3 of 3

• • 

    

    Sara Hurvitz, MD

    Peer

  • 

    

    Jacob Sands, MD

    Peer

  8

  

  RestartResume

  Clinical Considerations for Targeted Therapies Across Multiple Tumor Types

  Clinical Considerations for Targeted Therapies Across Multiple Tumor Types

  0.25 credits

• • 

    

    William J. Gradishar MD, FASCO, FACP

    Peer

  • 

    

    Peter Schmid, FRCP, MD, PhD

    Peer

  6

  

  RestartResume

  Perspectives for Clinical Practice: The Latest Advances for HER2-positive Metastatic Breast Cancer

  Perspectives for Clinical Practice: The Latest Advances for HER2-positive Metastatic Breast Cancer

  0.25 credits

• • 

    

    Javier Cortes, MD, PhD

    Peer

  • 

    

    Giuseppe Curigliano, MD, PhD

    Peer

  • 

    

    Peter Schmid, FRCP, MD, PhD

    Peer

  3

  

  RestartResume

  Applying Real-World Evidence to Improve Clinical Decision-Making for Patients with HR-positive/HER2-negative Metastatic Breast Cancer

  Applying Real-World Evidence to Improve Clinical Decision-Making for Patients with HR-positive/HER2-negative Metastatic Breast Cancer

  0.25 credits